Search

Author/Creator Cilliers, Cornelius

2. First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1). Issue 23 (10th August 2022)

Authors:
Ou, Sai-Hong Ignatius; Jänne, Pasi A.; Leal, Ticiana A.; Rybkin, Igor I.; Sabari, Joshua K.; Barve, Minal A.; Bazhenova, Lyudmila; Johnson, Melissa L.; Velastegui, Karen L.; Cilliers, Cornelius; Christensen, James G.; Yan, Xiaohong; Chao, Richard C.; Papadopoulos, Kyriakos P.
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 23(2022)
Page Start:
2530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle. Issue 1 (6th October 2018)

Authors:
Bartelink, Imke H.; Jones, Ella F.; Shahidi‐Latham, Sheerin K.; Lee, Pei Rong Evelyn; Zheng, Yanan; Vicini, Paolo; van 't Veer, Laura; Wolf, Denise; Iagaru, Andrei; Kroetz, Deanna L.; Prideaux, Brendan; Cilliers, Cornelius; Thurber, Greg M.; Wimana, Zena; Gebhart, Geraldine
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 106:Issue 1(2019)
Page Start:
148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗